Recombinant Mouse IL-18 (without BSA)

1. Hirano Y et al. IL-18 is not therapeutic for neovascular age-related macular degeneration. Nat Med. 20, 1372-5 (2014)(PMID:25473914)

1. Shen J et al. Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. J Cell Physiol. 229, 974-83 (2014)(PMID:24515951)

1. Iijima R et al. Interleukin-18 induces retinal pigment epithelium degeneration in mice. InveVis Sci. 55, 6673-8 (2014)(PMID:25237159)

1. Yoshida S et al. Involvement of neutrophils and interleukin-18 in nociception in a mouse model of muscle pain. Mol Pain. 14, 1744806918757286 (2018)(PMID:29353540)

Function

1. Earl PL et al. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathog. 16, e1008505 (2020)(PMID:32320436)
2. Inoue T et al. Interleukin-18 levels and mouse Leydig cell apoptosis during lipopolysaccharide-induced acute inflammatory conditions. J Reprod Immunol. 141, 103167 (2020)(PMID:32629316)